Federal contractor · SEATTLE, WA

ADAPTIVE BIOTECHNOLOGIES CORPORATION

ADAPTIVE BIOTECHNOLOGIES CORPORATION received $308.9K in federal contract obligations in FY2026, on 11 awards. Since FY2017: $3.5M. Its largest customer was Department of Veterans Affairs ($144.2K).

Obligations · FY2026: $308.9K
New awards: 11
Sole-source: 83%
Single offer: 11%

UEI: DMW5BNQ331K9

Small business

Open in the contracts explorer Relationship graph

Spending by fiscal year

Obligations per federal fiscal year (October–September).

206.3KFY2017
303.7KFY2018
418.4KFY2019
381.5KFY2020
184KFY2021
422.1KFY2022
665.2KFY2023
611.9KFY2024
-32.6KFY2025
308.9KFY2026

Top buying agencies

Obligations in FY2026.

Department of Veterans Affairs$144.2K47%
5 awards
Department of the Army$128.7K42%
1 awards
National Institutes of Health$36K12%
4 awards
Defense Health Agency$00.0%
1 awards

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

Health & medical$308.9K100%

Where the work was performed

Integrity signals

Shares of the year's obligations, next to the country's.

Low competition94%
US 39% · $289.4K
Sole-source awards83%
US 30% · $255K
Single-offer competitions11%
US 8.7% · $34.4K
Urgency justifications0.0%
US 5.1% · $0

A signal is a reason to look closer, not evidence of wrongdoing: most sole-source awards are lawful and justified.

Agencies awarding it sole-source contracts

Department of Veterans Affairs$89.8K
Department of Veterans Affairs · 1 awards
National Institutes of Health$36.5K
Department of Health and Human Services · 1 awards

Largest awards

CLONOSEQ FDA-CLEARED IN VITRO DIAGNOSTIC (IVD) TESTING SERVICES$245.7K
Department of the Army· Bexar County, TX· Health & medical· Mar 14, 2025 – Feb 18, 2026· W81K0025CA004
CLONO-SEQ TESTING.$243.8K
Department of Veterans Affairs· Cuyahoga County, OH· Health & medical· Dec 30, 2025 – Jun 1, 2026· 36C25026P0251
CLONOSEQ HAS RECEIVED CLEARANCE FROM THE FOOD AND DRUG ADMINISTRATION FOR AN IN VITRO DIAGNOSTIC TEST SERVICE THAT DETECTS BLOOD CANCER IN PATIENTS.$44.9K
Defense Health Agency· Montgomery County, MD· Health & medical· Feb 28, 2025 – Nov 26, 2025· HT001425P0034
ADAPTIVE BIOTECHNOLOGIES CORPORATION:1186779 [26-010014]$38.9K
National Institutes of Health· King County, WA· Health & medical· Sep 25, 2026 – Sep 25, 2026· 75N98026P01882
CLONOSEQ TESTING FOR BOSTON AND WEST HAVEN VA HCS$35.1K
Department of Veterans Affairs· Suffolk County, MA· Health & medical· May 29, 2026 – Aug 26, 2026· 36C24126N0614
DNA EXTRACTION SERVICES (IMMUNOSEQ)$20.7K
National Institutes of Health· Montgomery County, MD· Health & medical· Sep 15, 2021 – Sep 1, 2026· 75N93021P01430
REFERENCE LAB TESTING PORTLAND OREGON$19.5K
Department of Veterans Affairs· Multnomah County, OR· Health & medical· Aug 26, 2026 – Aug 26, 2026· 36C26026P0708
IMMUNOSEQ MMIGH SERVICE (SURVEY) QTY. 48$12.9K
National Institutes of Health· King County, WA· Health & medical· Dec 3, 2020 – May 28, 2026· 75N93021P00122

Competitors

Companies that win from the same buyers in the same markets: obligations by agency and industry compared over the last three fiscal years.

Compared on 6 markets (agency × industry), FY2024–FY2026.

BOSTONGENE CORPORATION$402K
WALTHAM, MA · 43% of this company's obligations are in markets they both serveNational Institutes of Health · Architectural, engineering, and related services
IUF - LEIBNIZ-INSTITUT FUR UMWELTMEDIZINISCHE FORSCHUNG GMBH$462.7K−100% in FY2026
DUSSELDORF, DEU · 43% of this company's obligations are in markets they both serveNational Institutes of Health · Architectural, engineering, and related services
CHEMOGENICS BIOPHARMA, LLC$341K−100% in FY2026
DURHAM, NC · 38% of this company's obligations are in markets they both serveNational Institutes of Health · Architectural, engineering, and related services

Showing the top 3 of 25 competitors. Open the profile for the full list.

Who sells to the same buyers in the same markets, not who wins against whom on a given contract. Prime contract obligations by the agency and NAICS code of each award; subawards are never added. A company is a family of legal entities, joined by parent UEI or, in part, by an AI reading of names.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026 · FY2024–FY2026.

Lobbying and PAC activity

Organizations in House lobbying disclosures and FEC records whose names an AI judgment matched to this company. Those records carry no identifier shared with contracts, so every match is by name.

Matched organizations

Adaptive BiotechnologiesAI match · 100%

Lobbying · 2024: $0; 4 reports
Lobbying · 2023–2024: $200K

Lobbying by year

2023$200K
4 reports
2024$0
4 reports

Top issues

Health issues4 reports
Budget and appropriations3 reports
Medicare and Medicaid3 reports

Who was contacted

U.S. HOUSE OF REPRESENTATIVES4 reports
U.S. SENATE4 reports
Office of Science & Technology Policy (OSTP)1 reports

Houses of Congress and federal agencies the reports list as contacted (a report names every one for all its issues).

Lobbying firms hired

Arnold & Porter Kaye Scholer LLP$200K
8 reports

Registrants who are individuals are counted, not named.

Lobbying amounts are the filers' own good-faith estimates on quarterly LD-2 reports (the law asks for amounts rounded to $10,000; under $5,000 need not be itemized), latest amendment only. When an organization files its own report, it replaces what outside firms report for it that quarter. Matches are by name. Lobbying and political giving are legal and public: they show engagement with government, not influence over any award. Correlation is not influence: these organizations' lobbying and their contracts are shown side by side, and nothing here implies either affected the other.

Source: Lobbying disclosures (LD-1 registrations, LD-2 quarterly reports, LD-203 contribution reports) (Clerk of the U.S. House of Representatives), data current to Oct 9, 2026, loaded Oct 9, 2026 · 2023–2026.

Source: Committees, candidates and committee contributions to candidates (Federal Election Commission), data current to Oct 9, 2026, loaded Oct 9, 2026 · 2026, 2024, 2022.

Matches: Analisa AI name judgments (entity-match@1), updated Oct 5, 2026.

Congress: members and bills

Through the organizations matched to this company: members of Congress whose campaigns received contributions from their PACs, and the bills their lobbying reports named. Shown beside the company's contracts as a comparison, not a cause.

Bills named in its lobbying reports

H.R. 2369 · VALID Act of 20231 report
118th Congress · Introduced · 2023

1 of 8 reports (2023–2024) name at least one bill. Bills and resolutions the current reports name in their issue descriptions, by number of reports. A report names what it lobbied on, not which side it took.

Amounts, members and bills are as recorded, shown side by side. They say nothing about why a contribution was made, how a member voted or what a report sought. A bill number written in a report is read as the measure of the Congress its context points to (a law's number, the Congress written next to it, the title), else of the Congress then sitting.

Source: Committees, candidates and committee contributions to candidates (Federal Election Commission), data current to Oct 9, 2026, loaded Oct 9, 2026.

Source: Lobbying disclosures (LD-1 registrations, LD-2 quarterly reports, LD-203 contribution reports) (Clerk of the U.S. House of Representatives), data current to Oct 9, 2026, loaded Oct 9, 2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026.